What could your Abbott Laboratories investment become?

Is Abbott Laboratories a dividend stock?

Yes — Abbott Laboratories (ABT) pays a dividend yield of 2%, paid quarterly. It pays out about 45% of its earnings as dividends — a balance between rewarding shareholders and reinvesting in the business. Abbott Laboratories is also a dividend aristocrat — a company with a long track record of raising its dividend year after year.

Abbott Laboratories pays dividends quarterly, so investors receive income quarterly.

What sector is Abbott Laboratories in?

Abbott Laboratories (ABT) is part of the Healthcare sector. Healthcare covers pharmaceuticals, medical devices, and health services. Demand tends to hold up across economic cycles because people need care in good times and bad. Abbott Laboratories trades at a price-to-earnings (P/E) ratio of around 28, which reflects how much investors are currently willing to pay for each dollar of the company's earnings.

💡 Diagnostics and medical devices. Calm and steady.

⚡ Owns the infant nutrition division Similac.

How is this projection calculated?

The calculator above assumes a 6% average annual return — roughly in line with long-term stock-market averages — and compounds your investment year by year. Dividend income is estimated from Abbott Laboratories's current 2% yield. These are educational projections based on historical averages. Actual returns may vary, and your capital is at risk.